FDA Adverse Event Injury Summary report: N

OT ULTRASMART METER

MDR report key: 1873317 · Received October 18, 2010

Report

Report Number
2939301-2010-09175
Event Type
Injury
Date Received
October 18, 2010
Date of Event
September 19, 2010
Report Date
October 5, 2010
Manufacturer
LIFESCAN, INC.
Product Code
NBW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT. 510K #K021819.

Description of Event or Problem · 1

THE MEDICAL SURVEILLANCE SPECIALIST (MSS) WAS UNABLE TO REACH THE LAY USER/PATIENT FOR FOLLOW-UP QUESTIONS. THE FOLLOWING COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED FROM LFS CUSTOMER SERVICE. THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) CUSTOMER SERVICE ON (B)(6) 2010 ALLEGING THAT THE ONETOUCH ULTRASMART METER DOES NOT TURN ON. THE PATIENT'S DIABETES IS MANAGED WITH SELF ADJUSTING INSULIN. THE POWER ISSUE BEGAN ON (B)(6) 2010 AT 6 AM. AS A RESULT OF THE POWER ISSUE, THE PATIENT MANAGED HIS DIABETES BY TAKING LESS FOOD AND/OR DRINK AT THE TIME OF CONCERN. 2 HOURS LATER, THE PATIENT CLAIMED THAT HE WAS SWEATING AND EVENTUALLY LOST CONSCIOUSNESS. THE PARAMEDICS ARRIVED AROUND THE SAME TIME AND TREATED THE PATIENT WITH IV GLUCOSE FOR A BLOOD GLUCOSE READING OF "28 MG/DL." ACCORDING TO THE TROUBLESHOOTING PERFORMED WITH CUSTOMER SERVICE, THE POWER ISSUE WAS NOT RESOLVED SINCE THE PATIENT DID NOT HAVE A REPLACEMENT BATTERY. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DECREASED HIS FOOD INTAKE AS A RESULT OF THE POWER ISSUE, PASSED OUT, AND RECEIVED MEDICAL INTERVENTION FOR HYPOGLYCEMIA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OT ULTRASMART METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN, INC.

Patients

Seq Age Sex Outcome Treatment
1 44 YR Life Threatening| R